Theuer Charles
- SEC CIK
- 0001631338
No open-market purchases or sales filed in the past year.
Current role at each company
- FDMT 4D Molecular Therapeutics, Inc.Directoras of Jun 18, 2026
- ONCT Oncternal Therapeutics, Inc.Directoras of Jun 24, 2024
- TCON Tracon Pharmaceuticals, Inc.PRESIDENT AND CEOas of Mar 13, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Theuer Charles as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
TCON Tracon Pharmaceuticals, Inc.
PRESIDENT AND CEO22 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 18, 2021 (view filing) | Aug 16 | 2 days | Theuer CharlesPresident and CEO | PPurchase | +3.00K | $3.56 | +$10.7K | +1.5%207.7K after | |
| Nov 9, 2021 (view filing) | Nov 5 | 4 days | Theuer CharlesPresident and CEO | PPurchase | +4.00K | $3.42 | +$13.7K | +1.9%215.1K after | 2 lots |
| Nov 22, 2021 (view filing) | Nov 18-19 | 4 days | Theuer CharlesPresident and CEO | PPurchase | +4.18K | $2.83 | +$11.8K | +1.9%219.3K after | 2 lots |
| Mar 23, 2022 (view filing) | Mar 21 | 2 days | Theuer CharlesPresident and CEO | PPurchase | +1.20K | $2.45 | +$2.94K | +0.5%220.5K after | |
| Apr 1, 2022 (view filing) | Mar 30 | 2 days | Theuer CharlesPresident and CEO | PPurchase | +4.00K | $2.70 | +$10.8K | +1.8%224.5K after | |
| Apr 12, 2022 (view filing) | Apr 8 | 4 days | Theuer CharlesPresident and CEO | PPurchase | +2.00K | $2.50 | +$5.00K | +0.9%226.5K after | |
| Apr 25, 2022 (view filing) | Apr 21 | 4 days | Theuer CharlesPresident and CEO | PPurchase | +4.50K | $2.30 | +$10.3K | +2.0%234.5K after | |
| May 3, 2022 (view filing) | Apr 29 | 4 days | Theuer CharlesPresident and CEO | PPurchase | +5.00K | $1.97 | +$9.85K | +2.1%239.5K after | |
| May 10, 2022 (view filing) | May 6 | 4 days | Theuer CharlesPresident and CEO | PPurchase | +2.50K | $1.97 | +$4.92K | +1.0%242.0K after | |
| May 11, 2022 (view filing) | May 9 | 2 days | Theuer CharlesPresident and CEO | PPurchase | +10.0K | $1.85 | +$18.5K | +4.1%252.0K after |